These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7258362)

  • 21. Rate-sensitive inhibition of ACTH release in depression.
    Carr DB; Wool C; Lydiard RB; Fisher J; Gelenberg A; Klerman G
    Am J Psychiatry; 1984 Apr; 141(4):590-2. PubMed ID: 6322599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD; Sullivan AC; Byrnes SM
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothalamic-pituitary-adrenal axis activity and age in major depression.
    Nelson WH; Orr WW; Shane SR; Stevenson JM
    J Clin Psychiatry; 1984 Mar; 45(3):120-1. PubMed ID: 6698943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. REM latency and DST results.
    Mendlewicz J
    Am J Psychiatry; 1984 Mar; 141(3):473-4. PubMed ID: 6703125
    [No Abstract]   [Full Text] [Related]  

  • 25. [Endocrinologic testing of alcoholics with depressive states--with special reference to the dexamethasone suppression test].
    Suwa K; Takano K; Nishijima K; Ishiguro T; Enomoto M
    Seishin Shinkeigaku Zasshi; 1983; 85(11):823-6. PubMed ID: 6677920
    [No Abstract]   [Full Text] [Related]  

  • 26. [Value and limits of conducting several neuro-endocrine tests in the diagnosis of depressive states].
    Schmitt L; Granier F; Girard M; Zarouk B; Escande M
    Ann Med Psychol (Paris); 1985 Feb; 143(2):166-74. PubMed ID: 3929664
    [No Abstract]   [Full Text] [Related]  

  • 27. Cortisol levels in plasma after dexamethasone administration and the nosology of depression.
    Sanchez Blanque A; Fernandez Canti G; Gimenez Morales JC; Juste Rullo G
    Acta Psychiatr Belg; 1985; 85(3):406-15. PubMed ID: 4050499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical utility of the dexamethasone suppression test in psychiatry. Summary of a National Institute of Mental Health workshop.
    Hirschfeld RM; Koslow SH; Kupfer DJ
    JAMA; 1983 Oct; 250(16):2172-4. PubMed ID: 6620522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression, hypothalamic-pituitary-adrenocortical activity, and lymphocyte function.
    Kronfol Z; House JD
    Psychopharmacol Bull; 1985; 21(3):476-8. PubMed ID: 4034861
    [No Abstract]   [Full Text] [Related]  

  • 31. Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis.
    Wardenaar KJ; Vreeburg SA; van Veen T; Giltay EJ; Veen G; Penninx BW; Zitman FG
    Biol Psychiatry; 2011 Feb; 69(4):366-73. PubMed ID: 21030010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In unipolar depression does the response to the dexamethasone suppression test predict a symptomatic recurrence after clinical cure?].
    Charles G; Schittecatte M; Maes JM; Rush AJ; Wilmotte J
    Acta Psychiatr Belg; 1986; 86(3):249-56. PubMed ID: 3751648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dexamethasone suppression test in fibrositis.
    Hudson JI; Pliner LF; Hudson MS; Goldenberg DL; Melby JC
    Biol Psychiatry; 1984 Oct; 19(10):1489-93. PubMed ID: 6596128
    [No Abstract]   [Full Text] [Related]  

  • 34. HPA axis abnormalities in depressed patients with normal response to the DST.
    Meller W; Kathol RG; Jaeckle RS; Grambsch P; Lopez JF
    Am J Psychiatry; 1988 Mar; 145(3):318-24. PubMed ID: 2830798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychological and neuroendocrinological characteristics associated with depressive symptoms in breast cancer patients at the initial cancer diagnosis.
    Seok JH; Kim LS; Hong N; Hong HJ; Kim SJ; Kang HJ; Jon DI
    Gen Hosp Psychiatry; 2010; 32(5):503-8. PubMed ID: 20851271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The dexamethasone suppression test and manic disorder].
    Maicas MJ; Atares JA; Valiente R; Balcells M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1985; 13(6):367-72. PubMed ID: 3834782
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axis findings in depressive disorder].
    Sarandöl A; Taneli B; Sivrioğlu Y
    Turk Psikiyatri Derg; 2003; 14(2):116-24. PubMed ID: 12844278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine measures in anorexia nervosa: comparisons with primary affective disorders.
    Müller EE; Cavagnini F; Panerai AE; Massironi R; Ferrari E; Brambilla F
    Adv Biochem Psychopharmacol; 1987; 43():261-71. PubMed ID: 3035890
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychoneuroendocrine strategies.
    Holsboer F
    Adv Psychosom Med; 1987; 17():185-233. PubMed ID: 3035904
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypothesis of a deficiency of central noradrenergic input in DST nonsuppressor depressed patients. A clinical study with determination of DST and plasma DOPEG: negative results.
    Loo H; Benkelfat C; Scatton B; Dennis T; Poirier MF; Vanelle JM; Olie JP; Susini de Luca H
    Adv Biochem Psychopharmacol; 1985; 40():99-102. PubMed ID: 4025042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.